Fleebs-Logo
Details werden geladen...

Regeneron's Phase 3 skin cancer miss adds to mounting failures in LAG-3

Regeneron Pharmaceuticals’ LAG-3 inhibitor called fianlimab has flunked a late-stage skin cancer trial, marking yet another blow for the drug class.

Ähnliche Seiten

https://endpoints.news/biomarins-rare-disease-therapy-shows-no-clinical-benefit-in-phase-3-test/

BioMarin's rare disease therapy shows no clinical benefit in Phase 3 test

https://endpoints.news/biomarins-rare-disease-therapy-shows-no-clinical-benefit-in-phase-3-test/
https://www.biospace.com/deals/regeneron-parabilis-set-out-to-create-new-drug-class-in-deal-worth-up-to-2-3b

Regeneron, Parabilis set out to create new drug class in deal worth up to $2.3B - BioSpace

https://www.biospace.com/deals/regeneron-parabilis-set-out-to-create-new-drug-class-in-deal-worth-up-to-2-3b
https://www.manilatimes.net/2026/05/17/tmt-newswire/globenewswire/nanobiotix-announces-presentation-of-part-1-data-from-a-randomized-phase-2-clinical-trial-evaluating-jnj-1900-nbtxr3-in-stage-3-inoperable-lung-cancer/2345706

Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer | The Manila Times

https://www.manilatimes.net/2026/05/17/tmt-newswire/globenewswire/nanobiotix-announces-presentation-of-part-1-data-from-a-randomized-phase-2-clinical-trial-evaluating-jnj-1900-nbtxr3-in-stage-3-inoperable-lung-cancer/2345706
https://heiligenhafen-touristik.de/listing/the-miss-frances-crape-myrtle-from-southern-living-vivid-foliage-vivid-flowering-ornamental-value-3-gal-nursery-pot-due-to-agricultural-laws-we-cannot-ship-to-ca-az-ak-or-hi?srsltid=214753069
 21,20 $

The Miss Frances Crape Myrtle from Southern Living, Vivid Foliage, Vivid Flowering, Ornamental Value, 3 gal, Nursery Pot, Due to Agricultural Laws, we Cannot Ship to CA, AZ, AK, or HI

https://heiligenhafen-touristik.de/listing/the-miss-frances-crape-myrtle-from-southern-living-vivid-foliage-vivid-flowering-ornamental-value-3-gal-nursery-pot-due-to-agricultural-laws-we-cannot-ship-to-ca-az-ak-or-hi?srsltid=214753069
https://www.manilatimes.net/2026/05/19/tmt-newswire/globenewswire/cullinan-therapeutics-to-present-initial-clinical-data-for-cln-978-in-treatment-refractory-rheumatoid-arthritis-and-systemic-lupus-erythematosus-at-eular-2026-congress/2346652

Cullinan Therapeutics to Present Initial Clinical Data for CLN-978 in Treatment-Refractory Rheumatoid Arthritis and Systemic Lupus Erythematosus at EULAR 2026 Congress | The Manila Times

https://www.manilatimes.net/2026/05/19/tmt-newswire/globenewswire/cullinan-therapeutics-to-present-initial-clinical-data-for-cln-978-in-treatment-refractory-rheumatoid-arthritis-and-systemic-lupus-erythematosus-at-eular-2026-congress/2346652